Key Points
- Director Jian David Sun sold 70,440 shares of 111, Inc. at an average price of $0.25, totaling $17,610, and his ownership fell by about 9.02% to 710,551 shares.
- The company said the sale was made to cover tax withholding obligations tied to vested equity awards. Sun also sold 29,280 shares the day before at an average price of $0.27.
- 111, Inc. (NASDAQ:YI) recently traded at $5.26 and carries a consensus Sell rating; Weiss Ratings also downgraded its view slightly from “sell (e+)” to “sell (d-)”.
111, Inc. Sponsored ADR (NASDAQ:YI - Get Free Report) Director Jian David Sun sold 70,440 shares of the firm's stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $0.25, for a total transaction of $17,610.00. Following the sale, the director owned 710,551 shares of the company's stock, valued at approximately $177,637.75. This represents a 9.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Jian David Sun also recently made the following trade(s):
- On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The shares were sold at an average price of $0.27, for a total transaction of $7,905.60.
111 Stock Performance
NASDAQ:YI opened at $5.26 on Friday. The firm has a market cap of $46.21 million, a P/E ratio of -5.26 and a beta of 0.66. 111, Inc. Sponsored ADR has a fifty-two week low of $2.48 and a fifty-two week high of $11.17. The firm has a 50-day simple moving average of $6.26 and a two-hundred day simple moving average of $5.58.
Analysts Set New Price Targets
Separately, Weiss Ratings upgraded shares of 111 from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Thursday, May 21st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, 111 has a consensus rating of "Sell".
Read Our Latest Analysis on 111
111 Company Profile
(
Get Free Report)
111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.
111, Inc's product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
